Local Ablation for Hepatocellular Carcinoma: 2024 Expert Consensus-Based Practical Recommendations of the Korean Liver Cancer Association

키워드

참고문헌 (75)

1. Chen MS, "A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma", Ann Surg, 243, pp.321~328 (2006)
2. Feng K, "A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma", J Hepatol, 57, pp.794~802 (2012)
3. Wang Y, "Radiofrequency ablation versus hepatic resection for small hepatocellular carcinomas : a meta-analysis of randomized and nonrandomized controlled trials", PLoS One, 9, pp.e84484~ (2014)
4. Korean Liver Cancer Association(KLCA)and National Cancer Center(NCC)Korea, "2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma", Clin Mol Hepatol, 28, pp.583~705 (2022)
5. Korean Liver Cancer Association(KLCA)and National Cancer Center(NCC)Korea, "2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma", Korean J Radiol, 23, pp.1126~1240 (2022)
6. Korean Liver Cancer Association(KLCA)and National Cancer Center(NCC)Korea, "2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma", J Liver Cancer, 23, pp.1~120 (2023)
7. Lee DH, "Radiofrequency ablation for intrahepatic recurrent hepatocellular carcinoma : long-term results and prognostic factors in 168 patients with cirrhosis", Cardiovasc Intervent Radiol, 37, pp.705~715 (2014)
8. European Association for the Study of the Liver, "EASL Clinical Practice Guidelines : management of hepatocellular carcinoma", J Hepatol, 69, pp.182~236 (2018)
9. European Association for the Study of the Liver, "EASL Clinical Practice Guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis", J Hepatol, 76, pp.1151~1184 (2022)
10. Lencioni R, "Early-stage hepatocellular carcinoma in patients with cirrhosis : long-term results of percutaneous image-guided radiofrequency ablation", Radiology, 234, pp.961~967 (2005)
11. Shiina S, "A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma", Gastroenterology, 129, pp.122~130 (2005)
12. Luo W, "Effects of radiofrequency ablation versus other ablating techniques on hepatocellular carcinomas : a systematic review and meta-analysis", World J Surg Oncol, 15, pp.126~ (2017)
13. Vietti Violi N, "Efficacy of microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma in patients with chronic liver disease : a randomised controlled phase 2 trial", Lancet Gastroenterol Hepatol, 3, pp.317~325 (2018)
14. Gupta P, "Overall survival and local recurrence following RFA, MWA, and cryoablation of very early and early HCC : a systematic review and Bayesian network meta-analysis", Eur Radiol, 31, pp.5400~5408 (2021)
15. Yu Q, "Percutaneous microwave ablation versus radiofrequency ablation of hepatocellular carcinoma : a meta-analysis of randomized controlled trials", Abdom Radiol(NY), 46, pp.4467~4475 (2021)
16. Rhim H, "Major complications after radio-frequency thermal ablation of hepatic tumors : spectrum of imaging findings", Radiographics, 23, pp.123~134 (2003)
17. Tripodi A, "Changing concepts of cirrhotic coagulopathy", Am J Gastroenterol, 112, pp.274~281 (2017)
18. Patel IJ, "Society of Interventional Radiology consensus guidelines for the periprocedural management of thrombotic and bleeding risk in patients undergoing percutaneous image-guided interventions : part II. Recommendations : endorsed by the Canadian Association for Interventional Radiology and the Cardiovascular and Interventional Radiological Society of Europe", J Vasc Interv Radiol, 30, pp.1168~1184 (2019)
19. de Baère T, "Adverse events during radiofrequency treatment of 582 hepatic tumors", AJR Am J Roentgenol, 181, pp.695~700 (2003)
20. Lencioni RA, "Small hepatocellular carcinoma in cirrhosis : randomized comparison of radiofrequency thermal ablation versus percutaneous ethanol injection", Radiology, 228, pp.235~240 (2003)
21. Shiina S, "Radiofrequency ablation for hepatocellular carcinoma : 10-year outcome and prognostic factors", Am J Gastroenterol, 107, pp.569~577 (2012)
22. Kang TW, "Aggressive intrasegmental recurrence of hepatocellular carcinoma after radiofrequency ablation : risk factors and clinical significance", Radiology, 276, pp.274~285 (2015)
23. Lee S, "Radiofrequency ablation vs. surgery for perivascular hepatocellular carcinoma : propensity score analyses of long-term outcomes", J Hepatol, 69, pp.70~78 (2018)
24. Song KD, "Hepatic resection vs percutaneous radiofrequency ablation of hepatocellular carcinoma abutting right diaphragm", World J Gastrointest Oncol, 11, pp.227~237 (2019)
25. Lee MW, "Updated 10-year outcomes of percutaneous radiofrequency ablation as first-line therapy for single hepatocellular carcinoma < 3 cm : emphasis on association of local tumor progression and overall survival", Eur Radiol, 30, pp.2391~2400 (2020)
26. Ni JY, "Meta-analysis of radiofrequency ablation in combination with transarterial chemoembolization for hepatocellular carcinoma", World J Gastroenterol, 19, pp.3872~3882 (2013)
27. Wang X, "Efficacy and safety of radiofrequency ablation combined with transcatheter arterial chemoembolization for hepatocellular carcinomas compared with radiofrequency ablation alone : a time-toevent meta-analysis", Korean J Radiol, 17, pp.93~102 (2016)
28. Lee S, "Preoperative gadoxetic acid-enhanced MRI for predicting microvascular invasion in patients with single hepatocellular carcinoma", J Hepatol, 67, pp.526~534 (2017)
29. Choi SH, "LI-RADS classification and prognosis of primary liver cancers at gadoxetic acidenhanced MRI", Radiology, 290, pp.388~397 (2019)
30. Rhim H, "Ultrasonography-guided percutaneous radiofrequency ablation of hepatocellular carcinomas : a feasibility scoring system for planning sonography", Eur J Radiol, 75, pp.253~258 (2010)
31. Lee MW, "Planning US for percutaneous radiofrequency ablation of small hepatocellular carcinomas(1-3 cm) : value of fusion imaging with conventional US and CT", MR images, 2013, pp.24, 958~965
32. Lee MW, "Percutaneous radiofrequency ablation of small(1-2 cm)hepatocellular carcinomas inconspicuous on B-mode ultrasonographic imaging : usefulness of combined fusion imaging with MRI and contrastenhanced ultrasonography", Can J Gastroenterol Hepatol, 2018, pp.7926923~ (2018)
33. Bhatia SS, "Is antibiotic prophylaxis for percutaneous radiofrequency ablation (RFA) of primary liver tumors necessary? Results from a single-center experience", Cardiovasc Intervent Radiol, 38, pp.922~928 (2015)
34. Chehab MA, "Adult and pediatric antibiotic prophylaxis during vascular and IR procedures : a Society of Interventional Radiology practice parameter update endorsed by the Cardiovascular and Interventional Radiological Society of Europe and the Canadian Association for Interventional Radiology", J Vasc Interv Radiol, 29, pp.1483~1501 (2018)
35. Chen PY, "The incidence of bacteremia and risk factors of post-radiofrequency ablation fever for patients with hepato-cellular carcinoma", Cancers(Basel), 13, pp.5303~ (2021)
36. Hoffmann R, "Prolonged antibiotic prophylaxis in patients with bilioenteric anastomosis undergoing percutaneous radiofrequency ablation", J Vasc Interv Radiol, 23, pp.545~551 (2012)
37. Lim H, "Clinical practice guideline for the management of antithrombotic agents in patients undergoing gastrointestinal endoscopy", Clin Endosc, 53, pp.663~677 (2020)
38. Rockey DC, "Liver biopsy", Hepatology, 49, pp.1017~1044 (2009)
39. Ahn SJ, "Real-time US-CT", MR fusion imaging for percutaneous radiofrequency ablation of hepatocellular carcinoma, 2017, pp.66, 347~354
40. Lee MW, "Percutaneous radiofrequency ablation of hepatocellular carcinoma : fusion imaging guidance for management of lesions with poor conspicuity at conventional sonography", AJR Am J Roentgenol, 198, pp.1438~1444 (2012)
41. Park HJ, "Fusion imaging-guided percutaneous biopsy of focal hepatic lesions with poor conspicuity on conventional sonography", J Ultrasound Med, 32, pp.1557~1564 (2013)
42. Song KD, "Fusion imaging-guided radiofrequency ablation for hepatocellular carcinomas not visible on conventional ultrasound", AJR Am J Roentgenol, 201, pp.1141~1147 (2013)
43. Huang JX, "The benefit of contrastenhanced ultrasound in biopsies for focal liver lesions : a retrospective study of 820 cases", Eur Radiol, 32, pp.6830~6839 (2022)
44. Wu W, "A multicenter randomized controlled study of contrast-enhanced US versus US-guided biopsy of focal liver lesions", Radiology, 305, pp.721~728 (2022)
45. Masuzaki R, "Utility of contrastenhanced ultrasonography with Sonazoid in radiofrequency ablation for hepatocellular carcinoma", J Gastroenterol Hepatol, 26, pp.759~764 (2011)
46. Dohmen T, "Efficacy of contrastenhanced ultrasonography in radiofrequency ablation for hepatocellular carcinoma", Intern Med, 51, pp.1~7 (2012)
47. Lee JY, "The AFSUMB consensus statements and recommendations for the clinical practice of contrast-enhanced ultrasound using Sonazoid", Ultrasonography, 39, pp.191~220 (2020)
48. Yanagisawa K, "Phagocytosis of ultrasound contrast agent microbubbles by Kupffer cells", Ultrasound Med Biol, 33, pp.318~325 (2007)
49. Huang Q, "Value of artificial ascites to assist thermal ablation of liver cancer adjacent to the gastrointestinal tract in patients with previous abdominal surgery", BMC Cancer, 20, pp.763~ (2020)
50. Rhim H, "Percutaneous radiofrequency ablation with artificial ascites for hepatocellular carcinoma in the hepatic dome : initial experience", AJR Am J Roentgenol, 190, pp.91~98 (2008)
51. Park SJ, "Reducing pain by artificial ascites infusion during radiofrequency ablation for subcapsular hepatocellular carcinoma", Cardiovasc Intervent Radiol, 44, pp.565~573 (2021)
52. Koda M, "Percutaneous sonographically guided radiofrequency ablation with artificial pleural effusion for hepatocellular carcinoma located under the diaphragm", AJR Am J Roentgenol, 183, pp.583~588 (2004)
53. Nakamura S, "Prevention of vagotonia and pain during radiofrequency ablation of liver tumors", Hepatol Res, 44, pp.1367~1370 (2014)
54. Yokoyama K, "Pain control in patients with hepatocellular carcinoma treated by percutaneous radiofrequency ablation : comparison of the efficacy of one-shot and continuous intravenous fentanyl delivery", Acta Radiol, 55, pp.1219~1225 (2014)
55. Dou Z, "Efficacy and safety of microwave ablation and radiofrequency ablation in the treatment of hepatocellular carcinoma : a systematic review and meta-analysis", Medicine(Baltimore), 101, pp.e29321~ (2022)
56. Wang C, "Multicenter randomized controlled trial of percutaneous cryoablation versus radiofrequency ablation in hepatocellular carcinoma", Hepatology, 61, pp.1579~1590 (2015)
57. Huang GL, "Multiple-electrode switching-based radiofrequency ablation vs. conventional radiofrequency ablation for single early-stage hepatocellular carcinoma ranging from 2 to 5 cm", Front Oncol, 10, pp.1150~ (2020)
58. Lee J, "Percutaneous radiofrequency ablation with multiple electrodes for medium-sized hepatocellular carcinomas", Korean J Radiol, 13, pp.34~43 (2012)
59. Laeseke PF, "Multiple-electrode radiofrequency ablation of hepatic malignancies : initial clinical experience", AJR Am J Roentgenol, 188, pp.1485~1494 (2007)
60. Suh YS, "No-touch vs. conventional radiofrequency ablation using twin internally cooled wet electrodes for small hepatocellular carcinomas : a randomized prospective comparative study", Korean J Radiol, 22, pp.1974~1984 (2021)
61. Park SJ, "Switching monopolar no-touch radiofrequency ablation using octopus electrodes for small hepatocellular carcinoma : a randomized clinical trial", Liver Cancer, 10, pp.72~81 (2021)
62. Lee DH, "Outcome of no-touch radiofrequency ablation for small hepatocellular carcinoma : a multicenter clinical trial", Radiology, 301, pp.229~236 (2021)
63. Ei S, "Cryoablation provides superior local control of primary hepatocellular carcinomas of >2cm compared with radiofrequency ablation and microwave coagulation therapy : an underestimated tool in the toolbox", Ann Surg Oncol, 22, pp.1294~1300 (2015)
64. Ahmed M, "Image-guided tumor ablation : standardization of terminology and reporting criteria. A 10-year update", Radiology, 273, pp.241~260 (2014)
65. Crocetti L, "Quality improvement guidelines for radiofrequency ablation of liver tumours", Cardiovasc Intervent Radiol, 33, pp.11~17 (2010)
66. Dodd GD, "Percutaneous radiofrequency ablation of hepatic tumors : postablation syndrome", AJR Am J Roentgenol, 185, pp.51~57 (2005)
67. Carrafiello G, "Post-radiofrequency ablation syndrome after percutaneous radiofrequency of abdominal tumours : one centre experience and review of published works", Australas Radiol, 51, pp.550~554 (2007)
68. Kim JW, "Embolization for bleeding after hepatic radiofrequency ablation", J Vasc Interv Radiol, 28, pp.356~365 (2017)
69. Chang IS, "Delayed hepatic rupture after radiofrequency ablation for colorectal hepatic metastasis : management with transcatheter arterial embolization", Ann Surg Treat Res, 87, pp.41~43 (2014)
70. Livraghi T, "Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis : is resection still the treatment of choice?", Hepatology, 47, pp.82~89 (2008)
71. Tan W, "Comparison of microwave ablation and radiofrequency ablation for hepatocellular carcinoma : a systematic review and meta-analysis", Int J Hyperthermia, 36, pp.264~272 (2019)
72. Kim R, "Percutaneous cryoablation for perivascular hepatocellular carcinoma : therapeutic efficacy and vascular complications", Eur Radiol, 29, pp.654~662 (2019)
73. Ko SE, "Comparison of procedurerelated complications between percutaneous cryoablation and radiofrequency ablation for treating periductal hepatocellular carcinoma", Int J Hyperthermia, 37, pp.1354~1361 (2020)
74. Song KD, "Percutaneous cryoablation for hepatocellular carcinoma", Clin Mol Hepatol, 22, pp.509~515 (2016)
75. Choi D, "Liver abscess after percutaneous radiofrequency ablation for hepatocellular carcinomas : frequency and risk factors", AJR Am J Roentgenol, 184, pp.1860~1867 (2005)

관련 논문AI추천